Patent · US Expired

&bgr;-endorphin peptides for treating muscle-wasting diseases

US6596778B1 · kind B1 · utility

0Cited by

0References

10Claims

0Family size

Assignee

The University of Birmingham · GB

Inventor

Margaret E. Smith · Birmingham, GB

Key dates

Filing date	Nov 26, 1999
Grant date	Jul 22, 2003
Priority date	—
Expiry date	Nov 26, 2019

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P21/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An active &bgr;-endorphin fragment or an analog of such a fragment is provided to a patient for alleviating the effect of muscle-wasting disease and for inhibiting or reducing leakage of an enzyme from a living muscle. The &bgr;-endorphin fragment is selected from &bgr;-endorphin (30, 31), &bgr;-endorphin (29-31), &bgr;-endorphin (28-31) and stabilized analogs thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.